Reaction of 4-oxo-4H-chromen-3-carbaldehydes 1 with phenylacetic acids 2 under mild conditions or microwave irradiation led to 3-phenyl-2-oxo-2H,5H-pyrano[3,2-c]chromen-5-yl acetates 3. At stronger conditions by-products 5-(2-hydroxybenzoyl)-3-phenyl-2H-pyran-2-ones 4 and 5-hydroxy-2H,10aH-pyrano[2,3-b]chromen-2-ones 5 were also obtained. 5-Hydroxy-and 5-alkyloxy-2H,5H-pyrano[3,2-c]chromen-2-ones 6 and 7, respectively were easily prepared by reaction of 3 with water or alcohols. Twelve synthesized compounds were evaluated on their antineoplastic activities on 60 human tumour cell lines panels in NCI USA. According to the screening results 3-phenyl-2H,5H-pyrano[3,2-c]chromen-2-one was discovered as a new leading skeleton suitable for further development. Some SAR conclusions were made. Antitubuline mechanism for the most active compound 3g has been proposed.
Introduction
Synthetic exploitation of 4-oxo-4H-chromen-3-carbaldehyde 1 and its derivatives results from their reactivity towards nucleophiles. The wide variety of heterocycles can be synthesized due to the presence of three electrophilic centres in the molecule of 1 and its ability to open or retain pyran-4-one ring. 1 Many of chromene derivatives exhibit significant biological activity, such as antitumour, 2, 3 antimycobacterial 4 or antiviral. 5 Recently we developed convenient synthesis of 2-oxo-2H,5H-pyrano[3,2-c]chromen-5-yl acetates 3 by heating of equimolar quantities of chromene-3-carbaldehyde 1 and phenylacetic acids 2 in acetic anhydride in the presence of catalytic amount of sodium acetate or potassium carbonate. 15, 16 When the mixture of 1 and 2 was heated at 60 -80 °C for 2 -3 h, the acetates 3a-3h were isolated as only products in 48 -81% yields. When the synthesis was accomplished in microwave oven at constant 80 °C, the yields of products 3 were slightly higher (68 -85%), but the duration of the reaction was considerably shorter (30 min). The mixture of propionic anhydride with aldehyde 1a and phenylacetic acid 2b heated at 80 °C for 2h, or under microwave irradiation at 110 °C for 30 min both in the presence of potassium carbonate led to 3-(4-fluorophenyl)-2-oxo-2H,5H-pyrano[3,2-c]chromen-5-yl propionate 3i in 80% yield (Scheme 1). In order to examine reaction profile and the thermal stability of acetates 3, the mixture of 1 and 2 was treated at 100 °C for 12 -22 h in Ac2O. At these conditions, acetates 3 were isolated as the main products in 11 -54%. The by-products 5-(2-hydroxybenzoyl)-3-phenyl-2H-pyran-2-ones 4 (1 -5%) together with rearranged compounds 5-hydroxy-3-phenyl-2H,10aH-pyrano [2,3-b] chromen-2-ones 5 (2 -4%) were obtained by flash chromatography of the crude reaction mixtures on SiO2 (Scheme 1).
5-Hydroxy-3-phenyl-2H,10aH-pyrano [2,3-b] chromen-2-one 5a was also prepared independently by rearrangement of 3a in acetic acid with catalytic amount of p-TsOH at 60 °C within 1 h in 74% yield. The compound 5b was partially converted to 5-ethoxy-3-(4-fluorophenyl)-2H,10aH-pyrano [2,3-b] chromen-2-one 8 during chromatography on SiO2 by traces of ethanol liberated from ethyl acetate eluent. Compound 8 can be also prepared from 5b by its heating in EtOH in the presence of catalytic amount of p-TsOH (Scheme 2). Scheme 1. The conditions for the synthesis of compounds 3a -8.
We have observed that the acetyloxy group at C(5) in the compounds 3 easily undergoes nucleophilic substitution. The acetates 3 were partially converted into their alcohols 6 during flash chromatography purification on SiO2. Therefore we have investigated the conditions for hydrolytic removing of AcO-group from 3 to prepare alcohols 6. Acid catalyzed reaction of 3a in the mixture of dioxane-water (3 : 1) at 50 °C within 2 h gave 74% of alcohol 6a. Stirring of 3 with water in THF for 15 -20 h at room temperature gave alcohols 6 in 26 -98% yields (Scheme 2). Alkyloxy derivatives 7 were prepared by heating of 3 in alcohol (prop-2-yn-1-ol or 2-thioethanol) in the presence of catalytic amount of p-toluenesulfonic acid. The reaction heated at 60 °C for 3 h gave 65 -75% of 7 compared to only 10 min microwave-assisted reaction that gives the yields 68 -77% (Scheme 2).
Based on structures and obtained activities we can conclude that para substitution at Ph-C(3) in compounds 3 or 6 decreases antitumour properties with no relation to the electronic properties of substituents. Therefore in this case unsubstituted compounds are the most suitable (R 1 : H or 4-F) 3g, 3h, 3b and 6a. Two methyl substituents in 3g, 3h lolcated in the skeleton on C(8) and C(9) seems to be important for the increase of antitumour activity. The most promising compounds 3b, 3g, 3h and 6a, derived from the results of One-dose prescreening, were further evaluated at five different concentrations (10 -5 to 10 -9 M) on 60 human tumour cell line panels (Table 2) . Compound 3g was shown to be the most active in slowing down tumour cell division compare to the control. Its structure contains unsubstituted phenyl group at C(3) and two methyl substituents at C(8) and C(9) ( Table 1 ). This compound possesses submicromolar mean growth inhibition activity over all 60 cancer cell lines panel (GI50: 447 nM). Individual tumour cell lines (e.g. Leukemia, NSCLC, Melanoma) have shown even nanomolar sensitivities for this compound (GI50: 31 -63 nM, not stated in this paper).
The exact mechanism of antitumour activity of compound 3g is not known. We believe that 3g interacts with tubulines. The proposed mechanism is based on comparison of GI50 activity profile for individual tumour cell lines (kind of finger print) with profile of standard antitumour compounds having known antitumour mechanism. Compare analysis software is accessible online and it is free of charge. 18 The compare analysis has been done with 3g inhibitor experimental GI50 values determined for all 60 human tumour cell lines (CC60 assays). These data were compared to sets of GI50 values of STANDARD_AGENTS taken from NCI database. A correlation between our most active compound 3g (NSC:745523) with compounds possessing typical antitubuline interactions has been obtained: e.g. rhizoxin with NCI code NSC:S332598 (correlation coefficient, 0.597), maytansine NSC:S153858 (0.438), paclitaxel NSC:S125973 (0.400), S-trityl-L-cysteine NSC:S83265 (0.374), vinblastine sulfate NSC:S49842 (0.358). The list of compounds with known antitubuline mechanism is published in NCI databases.
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Conclusions
A new leading skeleton with 3-phenyl-2H,5H-pyrano[3,2-c]chromen-2-one structure has been identified thank to the NCI tumour cell lines screening possibilities. 3-Phenyl-2-oxo-2H,5H-pyrano[3,2-c]chromen-5-yl acetates 3 were synthesized by the reaction of 4-oxo-4H-chromen-3-carbaldehydes 1 and substituted phenylacetic acids 2 in acetic anhydride. At stronger conditions, small amounts of two by-products 5-(2-hydroxybenzoyl)-3-phenyl-2H-pyran-2-ones 4 and 5-hydroxy-2H,10aH-pyrano [2,3-b] chromen-2-ones 5 were also obtained. Reaction of 3 with alcohols or water gave corresponding 5-hydroxy-and 5-alkyloxy 2H,5H-pyrano[3,2-c]chromen-2-ones 6 and 7, respectively. Synthesis of some derivatives 3 and 7 were significantly accelerated under microwave irradiation and completed within 10-30 min. Based on the antitumour screening results and Beilstein database searches we found that 3-phenyl-2H,5H-pyrano[3,2-c]chromen-2-ones represent a new type of antitumour compounds suitable for further development. 20 In our case the most active compounds were 3g, 3h, 3b and 6a (R 1 : H or 4-F). Para substituents R 1 at Ph-C(3) in compounds 3 or 6 decreasing antitumour activity independently on their electronic properties. On the other site methyl groups at C(8) and C(9) in 3g, 3h seems to be important for observed activities. We proposed that the antitumour activity of 3g performs via interaction with tubulines. This was based on comparisons of 3g GI50 profile with similar GI50 CC60 profiles of the standard agents from NCI database.
General. Melting points were determined on a Kofler hot plate apparatus and are uncorrected. 1 H NMR/ 13 C NMR spectra were obtained on a 300 MHz / 75 MHz VARIAN GEMINI 2000 spectrometer in CDCl3 or DMSO-d6 with tetramethylsilane as an internal standard. Elemental analyses were performed on CARLO ERBA STRUMENTAZIONE 1106 apparatus. IR spectra were recorded on FTIR-ATR REACT IR 1000 spectrometer in KBr or nujol. All microwaveassisted reactions were performed in an Initiator BIOTAGE microwave synthesizer. All solvents were distilled and dried appropriately prior to use. The course of reactions was monitored by TLC in ethyl acetate -hexane. Flash column chromatography was performed at SiO2 (Merck Silica gel 60) with hexane/ethyl acetate as eluent. 4-Oxo-4H-chromene-3-carbaldehyde was synthesized according to the method, described by Nohara. 21 The other chemicals were purchased from the suppliers as the highest purity grade. Antitumour activities were determined via Developmental Therapeutics Program (DTP) NCI / NIH in USA.
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General procedures for (R 1 -phenyl)-2-oxo-2H,5H-pyrano[3,2-c]chromen-5-yl acetates (3a-3h)
Method A. A mixture of 4-oxo-4H-chromene-3-carbaldehyde 1a or 1b (20.0 mmol, 1.00 mol eq) and substituted phenylacetic acid 2 (20.0 mmol, 1.00 mol eq) in freshly distilled acetic anhydride (10 mL) and fused sodium acetate (45.0 mg, 1.14 mmol, 0.06 mol eq) was stirred for 2 h at 60 -70 C. After cooling the solid product 3 was filtered off, washed with cold diethyl ether and crystallized from dioxane abs. Method B. A mixture of 4-oxo-4H-chromene-3-carbaldehyde 1a (20.0 mmol, 1.00 mol eq) and substituted phenylacetic acid 2 (20.0 mmol, 1.00 mol eq) in freshly distilled acetic anhydride (10 mL) and potassium carbonate (10.0 mg, 0.72 mmol, 0.04 mol eq) was irradiated in microwave oven at 80 °C and 20W for 30 min. The product 3 was isolated and purified in the same manner as described in Method A. Method C. A mixture of 4-oxo-4H-chromene-3-carbaldehyde 1a (500.0 mg, 2.87 mmol, 1.00 mol eq) and substituted phenylacetic acid 2 (3.14 mmol, 1.09 mol eq) in freshly distilled acetic anhydride (1.5 mL) and fused sodium acetate (49.4 mg, 0.21 mmol, 0.07 mol eq) was stirred for 12-16 h at 100 C under argon atmosphere. After cooling the yellow crystals were filtered off, washed with ethyl acetate (2 mL) and re-crystallized from ethyl acetate to give products 3. After evaporation of solvents, the products 4 and 5, respectively were separated by flash chromatography on SiO2 with hexane/ethyl acetate (3:1).
3-Phenyl-2-oxo-2H,5H-pyrano[3,2-c]chromen-5-yl acetate (3a)
. Method A, work-up as described above gave 81% of 3a, (method B, 85%, method C, 11%) as yellow powder: mp 230-232 °C (ethyl acetate 
3-(4-Fluorophenyl)-8,9-dimethyl-2-oxo-2H,5H-pyrano[3,2-c]chromen-5-yl acetate (3h).
Method A, work-up as described above gave 73% of 3h as yellow powder: mp 246-248 °C (ethyl acetate). Anal. calcd. for C22H17FO5 (380. 
General procedures for 3-(4-fluorophenyl)-2-oxo-2H,5H-pyrano[3,2-c]chromen-5-yl propionate (3i) Method D.
A mixture of 4-oxo-4H-chromene-3-carbaldehyde 1 (3.00 mmol, 1.00 mol eq) and 4-fluorophenylacetic acid 2b (3.00 mmol, 1.00 mol eq) in propionic anhydride (5 mL) and potassium carbonate (50.0 mg, 0.36 mmol, 0.12 mol eq) was stirred for 2 h at 80 C. After cooling, diethyl ether (20 mL) was added and the mixture was cooled at -10 °C for 1 h. The solid product was filtered off, washed with cold diethyl ether and crystallized from dioxane to give 80% of 3i as yellow powder.
Method E.
A mixture of 4-oxo-4H-chromene-3-carbaldehyde 1 (1.00 mmol, 1.00 mol eq) and 4-fluorophenylacetic acid 2b (1.00 mmol, 1.00 mol eq) in propionic anhydride (2 mL) and potassium carbonate (10.0 mg, 0.07 mmol, 0.002 mol eq) was irradiated in microwave oven at 110 °C and 20 W for 30 min. The product 3i was isolated and purified in the same manner as described in Method A to give 82% of 3i as yellow powder. Method D, work-up as described above gave 80% of 3i (method E, 82%) as yellow powder, m.p. Hydroxybenzoyl)-3-(3,4,5-trimethoxyphenyl)-2H-pyran-2-one (4d) . Method C, work-up as described above gave 5% of 4d, as yellow powder: mp 230-233 °C. Rf , CDCl3) δ 3.80 (s, 6H, 2 x CH3O). 3.89 (s, 3H, CH3O), 6.48 (s, 2H, H-2',6') 5-hydroxy-3-(R 1 -phenyl)-2H,10aH-pyrano[2,3-b] chromen-2-ones (5a-5c) Method F. Compound 3a (10.0 mmol) was dissolved in acetic acid (10 mL) and the solution was stirred at 60 °C for 1 h. After cooling the yellow precipitate was filtered off, washed with diethyl ether and crystallized from toluene or acetic acid. Method G. Compounds 5 as the side products were isolated by flash chromatography from the filtrate obtained after products 3 isolation (see Method C).
5-(2-
General procedures
5-Hydroxy-3-phenyl-2H,10aH-pyrano[2,3-b]chromen-2-one (5a).
Method F, work-up as described above gave 77% of 5a (method G, 2 %) as yellow powder: mp 256-258 °C. Rf 5-hydroxy-3-(R 1 -phenyl)-2H,5H-pyrano[3,2-c]chromen-2-ones (6a-6f) Method H. A mixture of acetate 3 (0.41 mmol, 1.00 mol eq) and p-toluenesulfonic acid (15 mg, 0.09 mmol, 0.22 mol eq) was heated in 50 mL of mixture dioxane-water (3:1) at 50 °C for 2 h. After cooling the solid product was filtered off, washed with cold diethyl ether and crystallized from dioxane. Method I. A mixture of acetate 3 (0.41 mmol, 1.00 mol eq), and water (0.5 mL, 27.8 mmol, 67.80 mol eq) in 0.5 mL of THF was stirred at room temperature for 15 h. Then the mixture was diluted with ethyl acetate (20 mL) and extracted with water (3 x 20 mL). The organic layer was dried with Na2SO4. After filtration and evaporation of ethyl acetate, the solid product was crystallized from dioxane.
General procedures for
5-Hydroxy-3-phenyl-2H,5H-pyrano[3,2-c]chromen-2-one (6a).
Method H, work-up as described above gave 74% of 6a as yellow powder: mp 150-151 °C (dioxane), Rf = 0 Hydroxy-3-(3,4,5-trimethoxyphenyl)-2H,5H-pyrano[3,2-c]chromen-2-one (6d) . Method I, work-up as described above gave 80% of 6d as yellow powder: mp 219-221 °C, Rf Method J: A solution of acetate 3 (3.00 mmol) and p-toluenesulfonic acid (8.0 mg, 0.04 mmol) in prop-2-yn-1-ol (10 mL) was heated at 60 °C for 3 h. After cooling, 30 mL of diethyl ether was added, the formed precipitate filtered off, washed with diethyl ether and crystallized from dioxane.
